Tuesday, June 21, 2016
- 12:30pm-2:00pm
-
Primidone-related connective tissue disorders in essential tremor
Tremor · Exhibit Hall located in Hall B, Level 2
- 12:30pm-2:00pm
-
Propranolol therapy for tardive dyskinesia: A retrospective examination
Drug-induced movement disorders · Exhibit Hall located in Hall B, Level 2
- 12:30pm-2:00pm
-
Protective effects of ATP13A2 in Parkinson’s disease models
Parkinson's disease: Genetics · Exhibit Hall located in Hall B, Level 2
- 12:30pm-2:00pm
-
Protein levels of SV2A and VGLUT1 in brain tissue from patients with Parkinson’s disease, dementia with Lewy bodies and Alzheimer’s disease
Parkinson's disease: Pathophysiology · Exhibit Hall located in Hall B, Level 2
- 12:30pm-2:00pm
-
Quantification of postural stability in Parkinson’s disease patients utilizing mobile technology
Technology · Exhibit Hall located in Hall B, Level 2
- 12:30pm-2:00pm
-
Quantifying daily living transitions in patients with Parkinson’s disease using a body-fixed sensor
Parkinson's disease: Pathophysiology · Exhibit Hall located in Hall B, Level 2
- 12:30pm-2:00pm
-
Quantifying turning behavior in Parkinson’s disease patients using mobile technology
Technology · Exhibit Hall located in Hall B, Level 2
- 12:30pm-2:00pm
-
Quantitative analysis of tremor in patients with cerebellar and brainstem lesions
Tremor · Exhibit Hall located in Hall B, Level 2
- 12:30pm-2:00pm
-
Quantitative assessment of advanced therapies in Parkinson’s disease using the Parkinson kinetigraph (PKG)
Technology · Exhibit Hall located in Hall B, Level 2
- «Previous Page
- 1
- …
- 35
- 36
- 37
- 38
- 39
- …
- 48
- Next Page»